Back
Aligos Therapeutics 10K Form
Sell
34
ALGS
Aligos Therapeutics
Last Price:
7.29
Seasonality Move:
-18.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALGS News And Ratings
See the #1 stock for the next 7 days that we like better than ALGS
ALGS Financial Statistics
Sales & Book Value
| Annual Sales: | $15.53M |
|---|---|
| Cash Flow: | $-19.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $21.07 |
| Price / Book: | 0.35 |
Profitability
| EPS (TTM): | -24.28530 |
|---|---|
| Net Income (TTM): | $-75.74M |
| Gross Margin: | -- |
| Return on Equity: | -110.22% |
| Return on Assets: | -65.26% |
Aligos Therapeutics Earnings Forecast
Key Aligos Therapeutics Financial Ratios
- The Research & Development expenses have been 470.35% of Revenue.
- The Net Earning history of ALGS is -564.61% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 4 years.
Aligos Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALGS |
| Website: | aligos.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.23 |
| Quick Ratio: | 4.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ALGS Technical Analysis vs Fundamental Analysis
Sell
34
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a Sell
The current Aligos Therapeutics [ALGS] share price is $7.38. The Score for ALGS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.